Monopar Therapeutics Inc
(MNPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 16,162 | 8,831 | 10,537 | 9,127 | 6,509 |
| Operating Income | -16,162 | -8,831 | -10,537 | -9,127 | -6,509 |
| Other Income | 575 | 429 | 21 | 24 | 204 |
| Pre-tax Income | -15,586 | -8,402 | -10,516 | -9,103 | -6,305 |
| Net Income Continuous | -15,586 | -8,402 | -10,516 | -9,103 | -6,305 |
| Net Income | $-15,586 | $-8,402 | $-10,516 | $-9,103 | $-6,305 |
| EPS Basic Total Ops | -4.11 | -3.04 | -4.15 | -3.65 | -2.90 |
| EPS Basic Continuous Ops | -4.11 | -3.04 | -4.13 | -3.65 | -2.88 |
| EPS Diluted Total Ops | -4.11 | -3.04 | -4.15 | -3.65 | -2.90 |
| EPS Diluted Continuous Ops | -4.11 | -3.04 | -4.13 | -3.65 | -2.88 |
| EPS Diluted Before Non-Recurring Items | -4.11 | -3.05 | -4.15 | -3.65 | -2.90 |
| EBITDA(a) | $-16,162 | $-8,831 | $-10,537 | $-9,127 | $-6,509 |